Tamiflu and Vyvanse drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tamiflu (oseltamivir phosphate) and Vyvanse (lisdexamfetamine dimesylate). Common drug interactions include renal failure among females and arterial occlusive disease among males.
The phase IV clinical study analyzes what interactions people have when they take Tamiflu and Vyvanse. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.
What is Tamiflu?
Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
57 people who take Tamiflu and Vyvanse together, and have interactions are studied.

What are the common drug interactions of Tamiflu and Vyvanse, by gender? *:
female:
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Renal injury (kidney injury)
- Rhinorrhoea (watery mucus discharge from the nose)
- Rib fracture
- Sinusitis (inflammation of sinus)
- Skin swelling
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Suppressed lactation
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
male:
- Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
- Artery dissection
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Memory impairment
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Abnormal behaviour
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Back pain
- Bladder disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
What are the common drug interactions of Tamiflu and Vyvanse, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Vomiting
10-19:
- Abnormal behaviour
- Headache (pain in head)
20-29:
- Acute psychosis (period of mentally unstable behaviour)
- Anxiety
- Hypertension (high blood pressure)
- Nasopharyngitis (inflammation of the nasopharynx)
- Respiratory syncytial virus infection (viral disease of respiratory system)
- Somnambulism (sleep walking)
- Weight increased
- Multiple allergies (allergy to multiple agents)
- Nasal septum deviation (deviated nasal septum)
30-39:
- Abdominal pain upper
- Anger
- Blood pressure increased
- Asthma
- Cardiac infection (an infection of the heart)
- Cerebral disorder (brain disease)
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
- Headache (pain in head)
- Malaise (a feeling of general discomfort or uneasiness)
- Nasal septum deviation (deviated nasal septum)
40-49:
- Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
- Artery dissection
- Blood pressure decreased
- Blood pressure increased
- Cervical vertebral fracture
- Eye pain
- Fall
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Urticaria (rash of round, red welts on the skin that itch intensely)
50-59:
- Asthenia (weakness)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Pneumonia
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Renal injury (kidney injury)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Tubulointerstitial nephritis and uveitis syndrome (a rare autoimmune disease a form of nephritis affecting the interstitium of the kidneys surrounding the tubules along with inflammation of the middle layer of the eye)
- Chronic kidney disease
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 40 people, 70.18%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 24 people, 42.11%
- Stress And Anxiety: 5 people, 8.77%
- Drowsiness: 5 people, 8.77%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.26%
- Immunodeficiency Common Variable: 3 people, 5.26%
- Hypersensitivity: 3 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Tamiflu and Vyvanse?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tamiflu and Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tamiflu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tamiflu and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on oseltamivir phosphate and lisdexamfetamine dimesylate (the active ingredients of Tamiflu and Vyvanse, respectively), and Tamiflu and Vyvanse (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ambien cause White Blood Cell Count Increased? - 12 seconds ago
- Could Linagliptin cause Renal Tubular Acidosis? - 13 seconds ago
- Robaxisal vs. Ultram Er, side effect and effectiveness comparison - 18 seconds ago
- Drug interactions of Metformin and Brivaracetam - 19 seconds ago
- Could Irbesartan cause Haematuria Aggravated? - 25 seconds ago
- Drug interactions of Turmeric and Gaba - 29 seconds ago
- Could Otezla cause Tumor? - 32 seconds ago
- Drug interactions of Letrozole and Keppra - 37 seconds ago
- Drug interactions of Acetaminophen And Hydrocodone Bitartrate and Epipen - 47 seconds ago
- Could Lidocaine cause Hepatitis Aggravated? - 48 seconds ago